Affimed NV (AFMD)
6.78
+0.04
(+0.59%)
USD |
NASDAQ |
Jun 18, 10:09
Affimed Cash from Investing (Quarterly): -0.0011M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.0011M |
| December 31, 2023 | 1.755M |
| September 30, 2023 | -40.78M |
| June 30, 2023 | -0.0034M |
| March 31, 2023 | -0.0086M |
| December 31, 2022 | 2.406M |
| September 30, 2022 | 2.094M |
| June 30, 2022 | 1.529M |
| March 31, 2022 | -0.1189M |
| December 31, 2021 | -2.749M |
| September 30, 2021 | 0.0099M |
| June 30, 2021 | -0.6522M |
| March 31, 2021 | -1.164M |
| December 31, 2020 | 8.410M |
| September 30, 2020 | -0.16M |
| June 30, 2020 | -3.205M |
| March 31, 2020 | 4.099M |
| December 31, 2019 | 7.674M |
| September 30, 2019 | 8.880M |
| June 30, 2019 | 8.385M |
| March 31, 2019 | -20.08M |
| December 31, 2018 | -17.88M |
| September 30, 2018 | -0.1655M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.1965M |
| March 31, 2018 | -0.1892M |
| December 31, 2017 | 9.381M |
| September 30, 2017 | -4.886M |
| June 30, 2017 | -0.1321M |
| March 31, 2017 | 4.753M |
| December 31, 2016 | 5.240M |
| September 30, 2016 | 5.305M |
| June 30, 2016 | -0.5364M |
| March 31, 2016 | -20.13M |
| December 31, 2015 | -0.0696M |
| September 30, 2015 | -0.1406M |
| June 30, 2015 | -0.0555M |
| March 31, 2015 | -0.0417M |
| December 31, 2014 | -0.0385M |
| September 30, 2014 | -0.3002M |
| June 30, 2014 | -0.022M |
| March 31, 2014 | -0.0356M |
| December 31, 2013 | -0.015M |
| September 30, 2013 | -0.0263M |
| June 30, 2013 | -0.0616M |
| March 31, 2013 | -0.1056M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-40.78M
Minimum
Sep 2023
8.880M
Maximum
Sep 2019
-0.18M
Average
0.0044M
Median
Cash from Investing (Quarterly) Benchmarks
| CureVac NV | -5.527M |
| InflaRx NV | 29.27M |
| MorphoSys AG | -- |
| BioNTech SE | -2.503B |
| Immatics NV | -262.66M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.87M |
| Cash from Financing (Quarterly) | -0.4529M |
| Free Cash Flow | -113.57M |
| Free Cash Flow Per Share (Quarterly) | -1.71 |
| Free Cash Flow to Equity (Quarterly) | -24.10M |
| Free Cash Flow to Firm (Quarterly) | -25.87M |
| Free Cash Flow Yield | -111.8% |